Howard Hughes Medical Institute’s Mondelez International MDLZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-278
Closed -$15K 312
2025
Q4
$15K Hold
278
0.01% 149
2025
Q3
$17.4K Sell
278
-1
-0.4% -$64 0.01% 128
2025
Q2
$18.8K Buy
+279
New +$18.6K 0.01% 117
2015
Q3
Sell
-35,278
Closed -$1.45M 172
2015
Q2
$1.45M Buy
35,278
+11,858
+51% +$465K 0.31% 63
2015
Q1
$845K Sell
23,420
-157,955
-87% -$5.71M 0.11% 77
2014
Q4
$6.59M Sell
181,375
-691
-0.4% -$25.2K 1.76% 15
2014
Q3
$6.24M Buy
182,066
+6,434
+4% +$234K 1.39% 17
2014
Q2
$6.61M Sell
175,632
-24,368
-12% -$891K 1.11% 14
2014
Q1
$6.91M Hold
200,000
0.98% 11
2013
Q4
$7.06M Hold
200,000
1.06% 15
2013
Q3
$6.28M Hold
200,000
0.96% 15
2013
Q2
$5.71M Buy
+200,000
New +$6.09M 1.88% 22

Other funds holding MDLZ

Howard Hughes Medical Institute's MDLZ Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Mondelez International (MDLZ) in Q1 2026, closing a stake of 278 shares — an estimated $15K sold.

Howard Hughes Medical Institute first reported a position in MDLZ in Q2 2013 and held it in 12 quarters. The position peaked at $7.06M in Q4 2013. 1,899 funds tracked by Wall St. Rank hold MDLZ as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Mondelez International position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 278 Mondelez International shares in Q1 2026, an estimated $15K.
  • Howard Hughes Medical Institute first reported a position in Mondelez International in Q2 2013 and held it in 12 quarters.
  • Howard Hughes Medical Institute's Mondelez International position peaked at $7.06M in Q4 2013.
  • 1,899 funds tracked by Wall St. Rank held Mondelez International as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.